Bio­con slammed with OAI; Hong Kong looks to WuXi for ADC abil­i­ties; Tan­vex Phar­ma launch­es CD­MO ser­vices 

Wel­come to End­points News’ man­u­fac­tur­ing roundup, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions and more.

This week we saw Bio­con Bi­o­log­ics in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER